Mental Health + Psychopharm Flashcards
About half of psychiatric illness begins by age 14
If you don’t have a lot of time with your peds/teens - at least ask about:
Anxiety, eating disorders, OCD, substance abuse.
What are some examples of broad based scales to determine if there may be any mental health or social-emotional problem?
PSC-17/35 (brief)
ASQ-SE/BITSEA/ECSA (longer)
Start PSC-17 at age ______
8 and up. It’s free - no fee.
What does the PSC-17 investigate?
I (internalizing (depression/anxiety)
A (attention)
E (externalizing) - OCD, conduct
AAP bright futures recommends depression screening for age _____.
Maternal depression
12 and up.
1,2,4 and 6 mo PP visits
Vanderbilt or SNAP-IV evaluate _______
Inattention/hyperactivity.
PHQ-9 administered to kids age _____
13 and up.
MCPAP Depression Guidelines for PCPs - interpretation and guidance for PSC-17
Guides dx of sub-clinical to mild, moderate or severe depression, discuss medications and follow up protocol.
Parts to assessing a suicidal plan
Straightforward/frank
Connect the Q with depressive or dysphoric symptom
Separate plans, urges, behavior
Acts?
Anything stops them from acting?
Could be a time where these feelings get worse - what would it take to keep you safe in that situation ?
Safety plans.
Anticipate and emphasize the need for relationships!
During assessment of MH disorders in children, make sure to provide impression, remind of strength, convey hope and review the treatment plan to encourage patient and parents.
Use “unspecified disorder” or “adjustment disorder” if you’re not sure of the dx after the first appointment.
T/F: you must always try CBT-based psychosocial treatment PRIOR to prescribing medication for preschoolers
True - except in mod-severe symptoms and functional impairment when there is a high risk of injury to self/others or worsening family dysfunction.
AACAP.org guidelines
MOA of ADHD stimulants (methylphenidate and amphetmine)
MPD: Blocks reuptake of DA and NE but little effect on presynaptic release of DA.
Amphetamine: DA and NE reuptake inhibitor and increases release of DA and NE.